67
41. Nam Hoon Cho, Young Tae Kim, and Jae WooK Kim. Alteration of Cell Cycle in
Cervical Tumor Associated with Human Papillomavirus – Cyclin-Dependent Kinase
Inhibitors-. Yonsei Medical Journal. Vol.43, No6, pp. 722-728, 2002.
42. Sisk EA, Robertson ES. Clinical implications of human papillomavirus infection. Front
Biosci 2002; 7: e77-84.
43. Farthing AJ, Vousden KH. Functions of human papillomavirus E6 e E7 oncoproteins.
Trends in Microbiology 2: 170-174, 1994.
44. Schiffmann MH, Briton LA, Devessa SS et al. Cervical Cancer. In: Cancer
epidemiology and prevention. Schottenfeld and JF Fraumeni Jr, Eds. Oxford University
Press, New York 1996:1090-1116.
45. Cheng JY, Meng CL, Chao CF et al. Human papillomaviruses type- related DNA and c-
myc oncogene alterations in colon cancer cell lines. Dis Colon Rectum 1991;34: 469-
474.
46. Bodaghi S, Yamanegi K, Xiao SY, da Costa M, Palefski JM, Zheng ZM. Colorectal
papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005; 11:
2862-7.
47. Weinberger, P.M., Yu, Z., ZerKowski, M., Chung, G. A Possible association of Human
Papilloma Virus With a Subset of Colorectal Adenocarcinomas. Journal of Clinical
Oncology, 2004 ASCO Annual Meeting Proceedings (Post- Meeting Edition); Vol 22,
No 14S ( July 15 Supplement ), 2004: 3544.
48. Boguszakova L, Hirsch I, Brichacek B, Faltyn J, Fric P Dvorakova H, Vonka V.
Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from
adenoma and adenocarcinoma of the colon. Acta Virol 1998 Jul; 32(4):303-8